About Us

Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
My Watchlist
Indicators
Local Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Phase 2 Trial

Recent news which mentions Phase 2 Trial

< Previous 1 2 3 4 5 6 7 8 9 Next >
BiomX's Acne Vulgaris Treatment Fails To Top Vehicle Treatment Cohort
Tickers PHGE
Tags News Phase 2 Trial Acne Vulgaris
From Benzinga
Vertex Unveils First Patient Results On Potential Diabetes Treatment
Tickers VRTX
Tags Briefs Biotech Phase 1 Trial
From Benzinga
Regenxbio Reveals Interim Data From Diabetic Retinopathy Gene Therapy Trial
Tickers RGNX
Tags Small Cap Health Care RGNX
From Benzinga
Bristol Myers' TYK2 Inhibitor Disappoints In Mid-Stage Ulcerative Colitis Study
Tickers BMY
Tags Health Care Trading Ideas Movers
From Benzinga
Denali Highlights Encouraging Early Data, Update For Amyotrophic Lateral Sclerosis Program
Tickers DNLI SNY
Tags General DNLI Market News
From Benzinga
Entera Bio's Formulated Human Parathyroid Hormone Shows Encouraging BMD Data
Tickers ENTX
Tags General Benzinga osteoporosis
From Benzinga
Vaxart Starts Recruitment In Mid-Stage COVID-19 Oral Vaccine Trial
Tickers VXRT
Tags Market News News Phase 2 Trial
From Benzinga
Takeda Discontinues Two Mid-Stage Narcolepsy Trials
Tickers TAK TKPHF
Tags Health Care TAK Benzinga
From Benzinga
Why Did Kaleido Shares Plunge 10% On Tuesday?
Tickers KLDO
Tags General Market News why it's moving
From Benzinga
Gemini Axes Chief Scientific Officer, 20% Of Staff To Focus On Geographic Atrophy Candidate
Tickers GMTX
Tags Penny Stocks Briefs Biotech
From Benzinga
EXCLUSIVE: Annovis Bio's Parkinson's Candidate Improves Speed, Motor Function Vs Placebo
Tickers ANVS
Tags Health Care Biotech Briefs
From Benzinga
Why Did RedHill Biopharma Shares Jump 12% Monday?
Tickers RDHL
Tags Movers Trading Ideas COVID/19 Coronavirus
From Benzinga
Enanta To Discontinue Internal Development Of NASH Candidates
Tickers ENTA
Tags General Market News Non Alcoholic steatohepatitis
From Benzinga
AnaptysBio Reveals Updated Imsidolimab Data In Severe Form Of Psoriasis
Tickers ANAB
Tags Briefs Biotech Benzinga
From Benzinga
CTI BioPharma's COVID-19 Candidate Misses Primary Endpoint Mark In Phase 2 Trial
Tickers CTIC
Tags Trading Ideas Movers COVID/19 Coronavirus
From Benzinga
Xenon Pharma Shares Jump After Epilepsy Treatment Phase 2 Data Meets Primary Endpoint
Tickers XENE
Tags XENE General Market News
From Benzinga
J&J's RSV Vaccine Candidate Shows 80% Efficacy In Older Adults
Tickers JNJ
Tags News Phase 2 Trial Health Care
From Benzinga
Eli Lilly's Mirikizumab Maintains Symptomatic Remission for Two Years In Ulcerative Colitis Patients
Tickers LLY
Tags Phase 2 Trial News Market News
From Benzinga
Precigen Posts Additional Interim Data From Type 1 Diabetes Trial
Tickers PGEN PRVB
Tags Health Care Trading Ideas Small Cap
From Benzinga
BioNTech Starts Dosing In Mid-Stage Colorectal Cancer Immunotherapy Trial
Tickers BNTX RHHBF RHHBY RHHVF
Tags Benzinga colorectal cancer RHHBF
From Benzinga
Minerva Posts Positive Bioequivalence Results For Schizophrenia Candidate Formulations
Tickers NERV
Tags Health Care Trading Ideas Movers
From Benzinga
AIM ImmunoTech Recruits hVIVO For Ampligen Trial For Prophylaxis Use Against Respiratory Viruses
Tickers AIM
Tags Contracts News AIM
From Benzinga
Regeneron-Roche Post Encouraging New Data For COVID-19 Antibody Cocktail
Tickers REGN RHHBF RHHBY RHHVF
Tags Briefs Biotech RHHBF
From Benzinga
Here's Why Editas Stock Dropped After Data From CRISPR-Based Retinal Disorder Candidate
Tickers EDIT
Tags Phase 2 Trial News Market News
From Benzinga
Adagio's COVID-19 Candidate Shows Prolonged Half-Life, Neutralization At Six Months
Tickers ADGI AZN AZNCF MRNA
Tags General AZNCF Phase 1 Trial
From Benzinga
Graybug Vision Posts Six-Month Extension GB-102 Data Of Wet AMD Trial
Tickers GRAY REGN
Tags Health Care Briefs Biotech
From Benzinga
Why Are I-Mab Shares Trading Higher On Tuesday?
Tickers IMAB MGNX MRK
Tags Briefs Biotech IMAB
From Benzinga
Valneva, Pfizer Lyme Disease Vaccine Candidate Drops-Off After 18 Months
Tickers PFE VALN
Tags General News Phase 2 Trial
From Benzinga
Ultragenyx Resumes Dosing Antisense Trial In Rare Neurogenetic Disorder
Tickers RARE
Tags Benzinga RARE Briefs
From Benzinga
Pfizer Kick Starts Late-Stage Study For COVID-19 Oral Antiviral For Post-Exposure Prophylaxis
Tickers PFE
Tags Market News COVID/19 Coronavirus PFE
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.